Akanda Corp.

NasdaqCM AKAN

Akanda Corp. Price to Earnings Ratio (P/E) on December 30, 2024

Akanda Corp. Price to Earnings Ratio (P/E) is NA on December 30, 2024, a NA change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Akanda Corp. 52-week high Price to Earnings Ratio (P/E) is -0.09 on June 07, 2024, which is NA below the current Price to Earnings Ratio (P/E).
  • Akanda Corp. 52-week low Price to Earnings Ratio (P/E) is -0.79 on January 17, 2024, which is NA below the current Price to Earnings Ratio (P/E).
  • Akanda Corp. average Price to Earnings Ratio (P/E) for the last 52 weeks is -0.29.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
NasdaqCM: AKAN

Akanda Corp.

CEO Ms. Katharyn Field
IPO Date March 15, 2022
Location United Kingdom
Headquarters 1a, 1b Learoyd Road
Employees 46
Sector Health Care
Industries
Description

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Similar companies

SNOA

Sonoma Pharmaceuticals, Inc.

USD 2.64

2.33%

LFCR

Lifecore Biomedical, Inc.

USD 6.43

1.10%

BFRI

Biofrontera Inc.

USD 1.05

-7.08%

DERM

Journey Medical Corporation

USD 3.73

-1.32%

StockViz Staff

January 15, 2025

Any question? Send us an email